TC
MED icon

TFS Capital’s Medifast MED Stock Holding History

TFS Capital’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-17,663
Closed -$732K – 221
2017
Q2 		$732K Buy
+17,663
New +$768K 0.29% 117
2016
Q4 		– Sell
-38,548
Closed -$1.46M – 829
2016
Q3 		$1.46M Buy
38,548
+3,220
+9% +$115K 0.35% 100
2016
Q2 		$1.18M Buy
35,328
+26,860
+317% +$867K 0.22% 140
2016
Q1 		$256K Buy
+8,468
New +$248K 0.04% 695
2015
Q4 		– Sell
-11,977
Closed -$322K – 839
2015
Q3 		$322K Buy
+11,977
New +$349K 0.03% 647

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

TFS Capital's MED Position: Q3 2017 in Review

TFS Capital sold out of Medifast (MED) in Q3 2017, closing a stake of 17,663 shares — an estimated $732K sold.

TFS Capital first reported a position in MED in Q3 2015 and held it in 5 quarters. The position peaked at $1.46M in Q3 2016. 168 funds tracked by Wall St. Rank hold MED as of Q3 2017.

  • TFS Capital reported no remaining Medifast position as of Q3 2017 after selling out during the quarter.
  • TFS Capital sold 17,663 Medifast shares in Q3 2017, an estimated $732K.
  • TFS Capital first reported a position in Medifast in Q3 2015 and held it in 5 quarters.
  • TFS Capital's Medifast position peaked at $1.46M in Q3 2016.
  • 168 funds tracked by Wall St. Rank held Medifast as of Q3 2017.

Based on TFS Capital's 13F filing for Q3 2017.